Cary Street Partners Financial LLC Has $4.26 Million Stake in UnitedHealth Group Incorporated $UNH

Cary Street Partners Financial LLC boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 95.2% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 13,653 shares of the healthcare conglomerate’s stock after purchasing an additional 6,657 shares during the quarter. Cary Street Partners Financial LLC’s holdings in UnitedHealth Group were worth $4,259,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in the business. Brighton Jones LLC lifted its position in UnitedHealth Group by 176.2% in the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate’s stock valued at $22,384,000 after acquiring an additional 28,231 shares in the last quarter. Revolve Wealth Partners LLC raised its stake in shares of UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate’s stock worth $2,033,000 after purchasing an additional 2,324 shares during the last quarter. Ted Buchan & Co boosted its position in shares of UnitedHealth Group by 4.0% during the first quarter. Ted Buchan & Co now owns 5,900 shares of the healthcare conglomerate’s stock valued at $3,090,000 after buying an additional 229 shares during the last quarter. Cynosure Group LLC raised its position in UnitedHealth Group by 26.7% in the 1st quarter. Cynosure Group LLC now owns 744 shares of the healthcare conglomerate’s stock valued at $390,000 after buying an additional 157 shares during the last quarter. Finally, Koss Olinger Consulting LLC purchased a new position in UnitedHealth Group during the 1st quarter worth $521,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $330.61 on Monday. The company has a quick ratio of 0.82, a current ratio of 0.82 and a debt-to-equity ratio of 0.71. The business has a 50 day moving average of $341.79 and a 200 day moving average of $315.98. The company has a market cap of $299.48 billion, a PE ratio of 17.26, a P/E/G ratio of 2.16 and a beta of 0.43. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $606.36.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, topping the consensus estimate of $2.87 by $0.05. The business had revenue of $113.16 billion during the quarter, compared to analyst estimates of $113.19 billion. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The company’s revenue for the quarter was up 12.2% on a year-over-year basis. During the same period in the prior year, the business earned $7.15 EPS. As a group, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 16th. Shareholders of record on Monday, December 8th will be issued a dividend of $2.21 per share. The ex-dividend date is Monday, December 8th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.7%. UnitedHealth Group’s dividend payout ratio is 46.14%.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on UNH shares. TD Cowen raised their price target on shares of UnitedHealth Group from $335.00 to $338.00 and gave the company a “hold” rating in a research report on Thursday, October 30th. Deutsche Bank Aktiengesellschaft lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 price target on the stock. in a research report on Wednesday, October 29th. Leerink Partners set a $410.00 price objective on shares of UnitedHealth Group and gave the company an “outperform” rating in a research report on Wednesday, October 29th. Barclays boosted their price objective on UnitedHealth Group from $352.00 to $386.00 and gave the stock an “overweight” rating in a report on Thursday, October 9th. Finally, Sanford C. Bernstein raised their price objective on UnitedHealth Group from $433.00 to $440.00 and gave the company an “outperform” rating in a report on Thursday, October 30th. Seventeen analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat.com, UnitedHealth Group presently has a consensus rating of “Hold” and a consensus price target of $385.54.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.